News

Chronic Kidney Disease Treatment Market to Reach $47.9 Billion, Globally, by 2032 at 4.0% CAGR: Allied Market Research

by

Increase in the prevalence of chronic kidney disease (CKD) and technological advancement in chronic kidney disease treatment drive the growth of the global Chronic Kidney Disease Treatment Market.  PORTLAND, Ore., June 20, 2023 /PRNewswire/ — Allied Market Research published a report, titled, “Chronic Kidney Disease Treatment Market by Treatment (Drugs and Dialysis), and by End User (Hospitals, … Read more

Minghui Pharmaceutical Inc. Announces First Patient Dosing in Phase 1 Clinical Studies of Both the Antibody-Drug Conjugate Programs Targeting TROP-2 or B7-H3 Respectively, for Treatment of Advanced or Metastatic Solid Tumors

by

SHANGHAI and HANGZHOU, China and WILMINGTON, Del., June 20, 2023 /PRNewswire/ — Minghui Pharmaceutical, Inc., a leading clinical-stage biopharmaceutical company, announced today that the first dosing has been completed in two phase 1 clinical studies evaluating MHB036C and MHB088C. The studies aim to determine the maximum tolerated dose (MTD), the recommended phase 2 dose (RP2D), … Read more

Chemotherapy Induced Anemia Market to Reach $5 Billion, Globally, by 2032 at 6.3% CAGR: Allied Market Research

by

Increase in the prevalence of cancer and rise in demand for chemotherapy-induced anemia treatment drive the growth of the global chemotherapy-induced anemia market. PORTLAND, Ore., June 20, 2023 /PRNewswire/ — Allied Market Research published a report, titled, “Chemotherapy Induced Anemia Market by Grade (Grade 1, Grade 2, and Grade 3 & 4), Treatment (Blood transfusion, Erythropoietin-Stimulating Agents, and Iron … Read more

Employers can be Catalyst to Enable Americans to Live Longer, Healthier Lives

by

Deloitte actuaries identify how all Americans could potentially live up to 95% of their years in good health and live to be nearly 90 years old  NEW YORK, June 20, 2023 /PRNewswire/ — Key takeaways Deloitte’s analysis found all Americans could potentially live up to 95% of their years in good health and live to … Read more

ADAC Luftrettung collabore avec Volocopter sur un eVTOL de nouvelle génération pour les services médicaux d’urgence

by

BRUCHSAL, Allemagne, 20 juin 2023 /PRNewswire/ — Aujourd’hui, ADAC Luftrettung et Volocopter ont conclu un partenariat de collaboration visant à personnaliser les aéronefs électriques à décollage et atterrissage verticaux (eVTOL) de nouvelle génération pour les services de sauvetage. Deux accords importants ont été signés au Salon du Bourget : l’un portant sur l’achat de deux avions VoloCity et … Read more

Springer Nature se Juntará aos Negócios OneSystem™ da Seegene como Parceiro Estratégico

by

Seegene anuncia parceria estratégica com a Springer Nature para expandir os Negócios OneSystem™ Seegene e Springer Nature lançarão em conjunto projeto global de desenvolvimento de ensaios Springer Nature expressa apoio ativo à visão da Seegene para promover a participação em toda a comunidade científica global SEUL, Coreia do Sul, 20 de junho de 2023 /PRNewswire/ … Read more

Suvoda élargit son conseil d’administration avec l’arrivée d’Irena Webster, vétérane des essais cliniques

by

PHILADELPHIE, 20 juin 2023 /PRNewswire/ — Suvoda LLC, une entreprise mondiale de technologie pour les essais cliniques spécialisée dans les études complexes dans des domaines thérapeutiques comme l’oncologie, le système nerveux central (SNC) et les maladies rares, a fait appel à Irena Lerentracht Webster pour rejoindre son conseil d’administration. Mme Webster est une dirigeante expérimentée … Read more

Longbio Pharma Presented Positive Topline Phase 1 Results for LP-003 at ERS2023

by

SOFIA, Bulgaria, June 20, 2023 /PRNewswire/ — Longbio Pharma (Suzhou) Co., Ltd. (abbreviated as “Longbio Pharma”), a pharmaceutical company that develops medicines for the treatment of allergy, asthma, ophthalmology and other autoimmune diseases, announced the phase I data of LP-003 (new generation of anti-IgE antibody) at the 29th Congress of European Rhinologic Society (ERS2023) Poster … Read more

Seed Group joins forces with New York-based biotechnology firm Dante Genomics to accelerate science for people in the MENA region

by

DUBAI, UAE and NEW YORK, June 20, 2023 /PRNewswire/ — With the aim of bringing the best of scientific solutions in healthcare to the MENA region, Seed Group, a company of the Private Office of Sheikh Saeed Bin Ahmed Al Maktoum, has announced a strategic partnership with New York-based biotechnology company Dante Genomics. From left to … Read more

SpliceBio Appoints David Favre, D.V.M., Ph.D., as Chief Development Officer to Accelerate Development of its Lead AAV Gene Therapy Program

by

Dr. Favre brings extensive experience in gene therapy, immunology and drug development Appointment comes at a pivotal time of Company growth as it prepares for clinical development and expands its pipeline into other gene therapies BARCELONA,Spain, June 20, 2023 /PRNewswire/ — SpliceBio, a genetic medicines company exploiting its proprietary Protein Splicing platform to develop next … Read more